Industry: Chemical & Material
Published Date: 2024-01-10
Pages: 130 Pages
Report ld: 3027299
Request Sample
Customized Report
Darunavir Ethanolate Market Size(US$)

CAGR 2024-2030
4.3%
Market Size,2030
USD 17
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Darunavir Ethanolate (CAS 635728-49-3) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
The global market for Darunavir Ethanolate was estimated to be worth US$ 13 million in 2023 and is forecast to a readjusted size of US$ 17 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030
Darunavir Ethanolate is an effective antiretroviral drug primarily used to treat patients with HIV/AIDS. The market demand for Darunavir Ethanolate has been continuously growing, driven by the expansion of the global HIV/AIDS treatment market and technological advancements. The market size has been expanding, covering various regions and countries. In the future, with the ongoing development in the healthcare industry and the increasing demand for HIV/AIDS treatment, the market for Darunavir Ethanolate is expected to continue its robust growth, providing patients with more efficient and convenient treatment options.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Darunavir Ethanolate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Darunavir Ethanolate by region & country, by Type, and by Application.
The Darunavir Ethanolate market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Darunavir Ethanolate.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Darunavir Ethanolate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Darunavir Ethanolate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Darunavir Ethanolate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Darunavir Ethanolate Product Introduction
1.2 Global Darunavir Ethanolate Market Size Forecast
1.2.1 Global Darunavir Ethanolate Sales Value (2019-2030)
1.2.2 Global Darunavir Ethanolate Sales Volume (2019-2030)
1.2.3 Global Darunavir Ethanolate Sales Price (2019-2030)
1.3 Darunavir Ethanolate Market Trends & Drivers
1.3.1 Darunavir Ethanolate Industry Trends
1.3.2 Darunavir Ethanolate Market Drivers & Opportunity
1.3.3 Darunavir Ethanolate Market Challenges
1.3.4 Darunavir Ethanolate Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Darunavir Ethanolate Players Revenue Ranking (2023)
2.2 Global Darunavir Ethanolate Revenue by Company (2019-2024)
2.3 Global Darunavir Ethanolate Players Sales Volume Ranking (2023)
2.4 Global Darunavir Ethanolate Sales Volume by Company Players (2019-2024)
2.5 Global Darunavir Ethanolate Average Price by Company (2019-2024)
2.6 Key Manufacturers Darunavir Ethanolate Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Darunavir Ethanolate Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Darunavir Ethanolate
2.9 Darunavir Ethanolate Market Competitive Analysis
2.9.1 Darunavir Ethanolate Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Darunavir Ethanolate Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Darunavir Ethanolate as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity 97%
3.1.2 Purity 98%
3.1.3 Purity 99%
3.1.4 Others
3.2 Global Darunavir Ethanolate Sales Value by Type
3.2.1 Global Darunavir Ethanolate Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Darunavir Ethanolate Sales Value, by Type (2019-2030)
3.2.3 Global Darunavir Ethanolate Sales Value, by Type (%) (2019-2030)
3.3 Global Darunavir Ethanolate Sales Volume by Type
3.3.1 Global Darunavir Ethanolate Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Darunavir Ethanolate Sales Volume, by Type (2019-2030)
3.3.3 Global Darunavir Ethanolate Sales Volume, by Type (%) (2019-2030)
3.4 Global Darunavir Ethanolate Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Scientific Research
4.1.3 Others
4.2 Global Darunavir Ethanolate Sales Value by Application
4.2.1 Global Darunavir Ethanolate Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Darunavir Ethanolate Sales Value, by Application (2019-2030)
4.2.3 Global Darunavir Ethanolate Sales Value, by Application (%) (2019-2030)
4.3 Global Darunavir Ethanolate Sales Volume by Application
4.3.1 Global Darunavir Ethanolate Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Darunavir Ethanolate Sales Volume, by Application (2019-2030)
4.3.3 Global Darunavir Ethanolate Sales Volume, by Application (%) (2019-2030)
4.4 Global Darunavir Ethanolate Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Darunavir Ethanolate Sales Value by Region
5.1.1 Global Darunavir Ethanolate Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Darunavir Ethanolate Sales Value by Region (2019-2024)
5.1.3 Global Darunavir Ethanolate Sales Value by Region (2025-2030)
5.1.4 Global Darunavir Ethanolate Sales Value by Region (%), (2019-2030)
5.2 Global Darunavir Ethanolate Sales Volume by Region
5.2.1 Global Darunavir Ethanolate Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Darunavir Ethanolate Sales Volume by Region (2019-2024)
5.2.3 Global Darunavir Ethanolate Sales Volume by Region (2025-2030)
5.2.4 Global Darunavir Ethanolate Sales Volume by Region (%), (2019-2030)
5.3 Global Darunavir Ethanolate Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Darunavir Ethanolate Sales Value, 2019-2030
5.4.2 North America Darunavir Ethanolate Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Darunavir Ethanolate Sales Value, 2019-2030
5.5.2 Europe Darunavir Ethanolate Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Darunavir Ethanolate Sales Value, 2019-2030
5.6.2 Asia Pacific Darunavir Ethanolate Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Darunavir Ethanolate Sales Value, 2019-2030
5.7.2 South America Darunavir Ethanolate Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Darunavir Ethanolate Sales Value, 2019-2030
5.8.2 Middle East & Africa Darunavir Ethanolate Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Darunavir Ethanolate Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Darunavir Ethanolate Sales Value
6.2.1 Key Countries/Regions Darunavir Ethanolate Sales Value, 2019-2030
6.2.2 Key Countries/Regions Darunavir Ethanolate Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Darunavir Ethanolate Sales Value, 2019-2030
6.3.2 United States Darunavir Ethanolate Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Darunavir Ethanolate Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Darunavir Ethanolate Sales Value, 2019-2030
6.4.2 Europe Darunavir Ethanolate Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Darunavir Ethanolate Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Darunavir Ethanolate Sales Value, 2019-2030
6.5.2 China Darunavir Ethanolate Sales Value by Type (%), 2023 VS 2030
6.5.3 China Darunavir Ethanolate Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Darunavir Ethanolate Sales Value, 2019-2030
6.6.2 Japan Darunavir Ethanolate Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Darunavir Ethanolate Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Darunavir Ethanolate Sales Value, 2019-2030
6.7.2 South Korea Darunavir Ethanolate Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Darunavir Ethanolate Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Darunavir Ethanolate Sales Value, 2019-2030
6.8.2 Southeast Asia Darunavir Ethanolate Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Darunavir Ethanolate Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Darunavir Ethanolate Sales Value, 2019-2030
6.9.2 India Darunavir Ethanolate Sales Value by Type (%), 2023 VS 2030
6.9.3 India Darunavir Ethanolate Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 DC Chemicals
7.1.1 DC Chemicals Company Information
7.1.2 DC Chemicals Introduction and Business Overview
7.1.3 DC Chemicals Darunavir Ethanolate Sales, Revenue and Gross Margin (2019-2024)
7.1.4 DC Chemicals Darunavir Ethanolate Product Offerings
7.1.5 DC Chemicals Recent Development
7.2 Selleck Chemicals
7.2.1 Selleck Chemicals Company Information
7.2.2 Selleck Chemicals Introduction and Business Overview
7.2.3 Selleck Chemicals Darunavir Ethanolate Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Selleck Chemicals Darunavir Ethanolate Product Offerings
7.2.5 Selleck Chemicals Recent Development
7.3 AbMole BioScience
7.3.1 AbMole BioScience Company Information
7.3.2 AbMole BioScience Introduction and Business Overview
7.3.3 AbMole BioScience Darunavir Ethanolate Sales, Revenue and Gross Margin (2019-2024)
7.3.4 AbMole BioScience Darunavir Ethanolate Product Offerings
7.3.5 AbMole BioScience Recent Development
7.4 MedChemExpress (MCE)
7.4.1 MedChemExpress (MCE) Company Information
7.4.2 MedChemExpress (MCE) Introduction and Business Overview
7.4.3 MedChemExpress (MCE) Darunavir Ethanolate Sales, Revenue and Gross Margin (2019-2024)
7.4.4 MedChemExpress (MCE) Darunavir Ethanolate Product Offerings
7.4.5 MedChemExpress (MCE) Recent Development
7.5 APExBIO Technology
7.5.1 APExBIO Technology Company Information
7.5.2 APExBIO Technology Introduction and Business Overview
7.5.3 APExBIO Technology Darunavir Ethanolate Sales, Revenue and Gross Margin (2019-2024)
7.5.4 APExBIO Technology Darunavir Ethanolate Product Offerings
7.5.5 APExBIO Technology Recent Development
7.6 Key Organics
7.6.1 Key Organics Company Information
7.6.2 Key Organics Introduction and Business Overview
7.6.3 Key Organics Darunavir Ethanolate Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Key Organics Darunavir Ethanolate Product Offerings
7.6.5 Key Organics Recent Development
7.7 Combi-Blocks
7.7.1 Combi-Blocks Company Information
7.7.2 Combi-Blocks Introduction and Business Overview
7.7.3 Combi-Blocks Darunavir Ethanolate Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Combi-Blocks Darunavir Ethanolate Product Offerings
7.7.5 Combi-Blocks Recent Development
7.8 Hairui Chemical
7.8.1 Hairui Chemical Company Information
7.8.2 Hairui Chemical Introduction and Business Overview
7.8.3 Hairui Chemical Darunavir Ethanolate Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Hairui Chemical Darunavir Ethanolate Product Offerings
7.8.5 Hairui Chemical Recent Development
7.9 LGC
7.9.1 LGC Company Information
7.9.2 LGC Introduction and Business Overview
7.9.3 LGC Darunavir Ethanolate Sales, Revenue and Gross Margin (2019-2024)
7.9.4 LGC Darunavir Ethanolate Product Offerings
7.9.5 LGC Recent Development
7.10 AstaTech
7.10.1 AstaTech Company Information
7.10.2 AstaTech Introduction and Business Overview
7.10.3 AstaTech Darunavir Ethanolate Sales, Revenue and Gross Margin (2019-2024)
7.10.4 AstaTech Darunavir Ethanolate Product Offerings
7.10.5 AstaTech Recent Development
8 Industry Chain Analysis
8.1 Darunavir Ethanolate Industrial Chain
8.2 Darunavir Ethanolate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Darunavir Ethanolate Sales Model
8.5.2 Sales Channel
8.5.3 Darunavir Ethanolate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Darunavir Ethanolate was estimated to be worth US$ 14.46 million in 2025 and is projected to reach US$ 19.33 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 129
USD 3950.00
(Single User License)
The global Darunavir Ethanolate market was valued at US$ 14.46 million in 2025 and is anticipated to reach US$ 19.33 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 126
USD 2900.00
(Single User License)
The global Darunavir Ethanolate market is projected to grow from US$ 13.9 million in 2024 to US$ 18.6 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-21
Pages: 140
USD 4900.00
(Single User License)
The global market for Darunavir Ethanolate was valued at US$ 13.9 million in the year 2024 and is projected to reach a revised size of US$ 18.6 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-02-15
Pages: 92
USD 2900.00
(Single User License)
The global Darunavir Ethanolate market size was US$ 13.9 million in 2024 and is forecast to a readjusted size of US$ 18.6 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 80
USD 4250.00
(Single User License)
The global market for Darunavir Ethanolate was estimated to be worth US$ 13.9 million in 2024 and is forecast to a readjusted size of US$ 18.6 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 100
USD 3950.00
(Single User License)
Darunavir Ethanolate (CAS 635728-49-3) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
Published Date: 2024-04-12
Pages: 105
USD 4900.00
(Single User License)
Darunavir Ethanolate (CAS 635728-49-3) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
Published Date: 2024-02-26
Pages: 102
USD 2900.00
(Single User License)
The global market for Darunavir Ethanolate was estimated to be worth US$ 14.46 million in 2025 and is projected to reach US$ 19.33 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-07-14
Pages: 129
The global Darunavir Ethanolate market was valued at US$ 14.46 million in 2025 and is anticipated to reach US$ 19.33 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-04-21
Pages: 126
The global Darunavir Ethanolate market is projected to grow from US$ 13.9 million in 2024 to US$ 18.6 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-21
Pages: 140
The global market for Darunavir Ethanolate was valued at US$ 13.9 million in the year 2024 and is projected to reach a revised size of US$ 18.6 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-02-15
Pages: 92
The global Darunavir Ethanolate market size was US$ 13.9 million in 2024 and is forecast to a readjusted size of US$ 18.6 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 80
The global market for Darunavir Ethanolate was estimated to be worth US$ 13.9 million in 2024 and is forecast to a readjusted size of US$ 18.6 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 100
Darunavir Ethanolate (CAS 635728-49-3) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
Published: 2024-04-12
Pages: 105
Darunavir Ethanolate (CAS 635728-49-3) is an HIV protease inhibitor,showed potent activity against COVID-19(SARS-COV-2).
Published: 2024-02-26
Pages: 102
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now